A. Menarini Asia-Pacific Holdings Pte. Ltd.: Menarini and Sc

Vaborem, a patented combination of meropenem and vaborbactam, is expected to address the rising prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections in ChinaThe deal brings

Related Keywords

China , Italy , United States , Singapore , Italian , America , Chong Zhao , Christine Ann Miller , Maurizio Luongo , Menarini Asia Pacific , Sciclone Pharmaceuticals Holdings Limited , World Health Organization , China Antimicrobial Surveillance Network , Sciclone Pharmaceuticals Holdings , European Union , Menarini Group , Sciclone Pharmaceuticals , Prnewswirea Menarini Asia Pacific Holdings Pte , Melinta Therapeutics , Menarini Asia Pacific Holdings , Chief Executive Officer , License Agreement , Independent States , Clone Pharmaceuticals , Cidara Therapeutics , Menarini , Sia , Acific , Oldings , Ciclone , Sign , Exclusive , Icensing , Agreement , Evelop , Ommercialize , Laborem , Treat , Antimicrobial , Resistant , Infections ,